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ORIGINAL ARTICLE

Effectiveness of a community-based positive prevention
intervention for people living with HIV who are not receiving
antiretroviral treatment: a prospective cohort study
Avina Sarna,a Stanley Luchters,b,c,d,e Eustasius Musenge,c Jerry Okal,f Matthew Chersich,b,c
Waimar Tun,g Sabine Mall,h Nzioki Kingola,h Sam Kalibalag
In Mombasa, Kenya, a community-based HIV risk-reduction intervention effectively reached people living
with HIV who were not receiving antiretroviral treatment (ART)—a difficult-to-reach population because
they often fall outside the ambit of health care services—and succeeded in reducing reported risky sex
behavior and increasing ART uptake.

ABSTRACT
Background: We report effectiveness of an HIV-prevention intervention delivered by community health
workers (CHWs) in Mombasa, Kenya, to PLHIV who have not initiated or who have discontinued ART—
an often difficult-to-reach population because they fall outside the ambit of health care and prevention
services.
Methods: A 2-arm cohort study assessed a structured risk-reduction intervention involving at least 4 oneto-one counseling sessions and personalized support. The control group received standard prevention
services. CHWs recruited treatment-naı̈ve people living with HIV (PLHIV) or those who had previously
taken antiretroviral drugs. Data were analyzed using a Propensity Score Matched (PSM)-sample to
control for baseline differences between the groups.
Results: 634 PLHIV were recruited and followed for 6 months. Median age was 35 years, and 74.3%
were female. Participants in the intervention group reported reduced risky sexual behaviors both at endline
compared with baseline and compared with the control group. At endline, in the PSM analysis, participants
in the intervention arm were less likely than participants in the control group to report unprotected sex with a
spouse (Odds Ratio [OR]50.08, 95% confidence interval [CI]50.03-0.24), and they reported fewer
unprotected sex acts (12.3% versus 46.0%, respectively; OR50.16, 95% CI50.09-0.29; P,0.001).
Further, 92.4% of participants in the intervention group reported zero unsafe sex acts (with partners of
negative or unknown HIV status) compared with 70.8% in the control group (P,0.001), and more
participants in the intervention arm were receiving ART (34.3% versus 12.7%, respectively; P,0.001).
Conclusion: CHWs effectively reached PLHIV who had never received or who had discontinued ART,
and they delivered a risk-reduction intervention that led to declines in reported sexual risk behaviors, as
well as to increases in ART uptake. A scaled-up intervention warrants consideration.
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INTRODUCTION

P

eople living with HIV (PLHIV) comprise
those who do and those who do not know
their HIV status; both groups constitute important populations for HIV prevention. Among
those who know their status, PLHIV who receive
antiretroviral therapy (ART) and those who are
not yet eligible for treatment but access HIV care
for regular follow-up, such as for co-trimoxazole
prophylaxis, have frequent contact with health
services and are exposed to prevention informaMany PLHIV have tion and commodities. However, many PLHIV
have infrequent or no contact with health
infrequent or no
services, mostly because they are not yet eligible
contact with
for treatment, have not had contact with an ART
health services.
center, or have declined or discontinued ART.
HIV-prevention programs in low- and middle-income countries rarely have direct contact
with PLHIV not accessing services, apart from
mass media campaigns, for example. There are
very few positive prevention studies (prevention
aimed at PLHIV) among PLHIV who know their
status but are not accessing treatment. Our
previous study showed that high-risk sexual
behaviors are common in this group, which can
Positive prevention interventions place PLHIV at higher risk of superinfection or of
focus on reducing acquiring new sexually transmitted infections
risky sex behav- (STIs) and put their partners without HIV at risk
iors among PLHIV. of infection. Unprotected sex occurred in about
half of sexual partnerships, notably one-third of
them with partners without HIV and slightly
more than one-half with partners of unknown
HIV status.1
To date, most HIV-prevention studies targeting populations with HIV in the United States2-4
and developing countries5-9 have been among
those accessing health services, such as HIV
testing and counseling (HTC) centers, HIV care
or treatment services, family planning clinics,
maternal and child health clinics, or STI services.
Interventions evaluated in these studies varied in
frequency, delivery format, and content, and
covered a combination of risk assessment, risk
reduction,
partner
testing,
HIV-status
disclosure, and promotion of condom use. A
systematic review and meta-analysis of HIVprevention interventions suggest that interventions tend to be more successful in reducing risky
behaviors if they are based on behavioral theory,
specifically designed to change HIV-transmission
risk behaviors, and delivered to individuals in an
intensive manner and with skills building by
health care providers in service settings.4
Global Health: Science and Practice 2013 | Volume 1 | Number 1
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In 2010, in low- and middle-income countries, ART coverage was around 47% among the
14.2 million eligible persons.10 In Kenya, in 2009,
of the estimated 1.4 million PLHIV, 438,000 had
advanced disease (defined as CD4 ,200 cells/
mm3) and were eligible for treatment. About
309,000 were receiving ART.11 These figures
show that the majority of PLHIV, many of whom
are not yet eligible for ART, fall outside the ambit
of regular health care and preventive services.
Many PLHIV do not reach or access care services
after their HIV tests, with early pre-ART losses of
up to 33% among newly diagnosed PLHIV.12-14
An estimated 100,000 new adult HIV infections occurred in 2009 in Kenya,11 highlighting
the need for intensive combination prevention
efforts, including those focused on the sexual
risk behaviors of PLHIV, the large majority of
whom do not access HIV care services. In this
paper, we present findings from a 2-arm cohort
study in Mombasa, Kenya, with pre- and postmeasures. This controlled study aimed to assess
the effectiveness of a personalized HIV riskreduction intervention delivered by community
health workers (CHWs) to PLHIV who know
they have HIV and who are not on treatment.
The intervention was aimed primarily at reducing the number of unprotected sex acts and
sexual partners and to increase disclosure.
Secondarily, we assessed the effects of the
intervention on stigma and ART uptake. This
paper addresses a key population that has not
been studied and adds important evidence to
current literature on combination Prevention
with Positives (PwP).

METHODS
Samples and Procedures
The study was conducted in Changamwe and
Likoni Divisions of Mombasa, Kenya. The 2
divisions are geographically distinct, approximately 11 km apart, but they have a similar
HIV prevalence (about 6% of adults in a 2010
sentinel survey15). The divisions also have
comparable commercial activity related to the
port, tourism industry, and small-scale businesses, and they have similar networks of health
centers, HTC centers, and CHWs.
CHWs have a wide reach in the community
through various programs (for example, antenatal
care, social support, and nutrition services from
faith-based organizations) and could theoretically
reach PLHIV assigned to both the control and
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treatment groups. Thus, to retain intervention
integrity and avoid contamination, participants
recruited from Changamwe Division were assigned
to the intervention arm and those recruited from
Likoni, to the control arm. Participants in both
groups were followed for 6 months. Baseline and
endline data were collected in both groups.
Study participants were recruited by CHWs
using non-probability targeted sampling, an
approach where field-based outreach workers
actively recruit participants from identified geographic areas and populations of interest based
on a prior ethnographic assessment.16 CHWs are
lay health workers used widely in communitybased programs, including social support services, and are familiar with the community and
its socio-demographic profile. Local CHWs were
asked to undertake a descriptive ethnographic
assessment of the population in the selected
study areas. Information was sought on socioeconomic status, tribes, religious groups, and
presence of high-risk groups and PLHIV.
PLHIV in Mombasa are poorly networked and
reluctant to reveal their status.17 As there is no
listing of PLHIV in the community, each CHW
first identified 2 to 3 unrelated index PLHIV and
then asked the index PLHIVs to connect the
CHW to other PLHIV they knew. The CHW
identified a new index PLHIV if the previous
PLHIV did not know any other PLHIV. To limit
biases related to recruiter characteristics and
consequent oversampling of participants with
similar characteristics, each CHW could recruit
up to 20 participants. This allowed all CHWs in the
study to recruit PLHIV from their communities
and networks while avoiding the potential for
some CHWs to recruit a large and disproportionate
number of PLHIV from a single group that they
served (such as female sex workers, men who have
sex with men, or injection drug users [IDUs]).
Ethical approval was obtained from the
Kenyatta National Hospital’s Ethics Committee
in Kenya and the Institutional Review Board of
the Population Council in the United States.
Recruitment followed a detailed protocol on
approaching PLHIV, maintaining confidentiality,
and verifying the participant’s HIV status by
checking HIV/CD4 test results or the referral card
issued by an HCT center.
CHWs approached PLHIV in the community
they served and arranged a time and convenient
place to meet. CHWs then confirmed their HIV
status, provided information on the study, and
assessed willingness to participate and be followed
Global Health: Science and Practice 2013 | Volume 1 | Number 1
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over 6 months. Following this, the CHW fixed a
time to accompany the potential participant to
the study site. Trained study staff then assessed
participants for eligibility and enrolled participants
after completing informed consent procedures.
Eligible participants included residents of
Changamwe or Likoni who were sexually active
(had sex at least once in the past 3 months) adults
with HIV and were either ART naı̈ve or had taken
antiretroviral drugs at least 6 months previously
for any indication, including ART or prevention of
mother-to-child transmission of HIV (PMTCT).

Intervention Description
CHWs in the intervention arm underwent intensive 7-day training on study procedures and the
national orientation package for community HIV
service providers.18 These CHWs were trained in
counseling methods and motivational techniques
to assist clients with HIV to identify barriers to
safe sex that they faced, to help clients discuss
strategies to overcome these barriers and set
goals until the next meeting, and to encourage
and support clients in achieving these goals.
CHWs from the control site were trained for 3
days on study procedures and PLHIV recruitment. They also received training on the intervention after study completion.
The intervention, provided over a period of 6
months, consisted of a minimum of 4 structured
CHW meetings with the participant, each meeting lasting 30–60 minutes. No maximum number of visits was stipulated. In these sessions,
CHWs counseled participants on HIV/STI risk
reduction and treatment, consistent and correct
use of condoms, disclosure of HIV status to
partners, HIV testing for partners and children,
registering for HIV treatment, family planning,
and PMTCT.
The participants and CHWs met at a mutually
convenient location, for instance, at a health
center, HTC center, post-test club, or the participant’s home. CHWs used flipcharts to maintain
uniformity of message content and to demonstrate correct usage of condoms. All counseling
and contact with participants was conducted in
individual one-to-one sessions. The spouse or
main sexual partner could participate during prearranged couple counseling sessions with the
consent of the study participant. See box for
details of the counseling schedule and content.
CHWs contacted participants in the control
arm at baseline and endline. These CHWs
continued to provide routine support services to

54

Effectiveness of HIV-prevention intervention provided by CHWs to untreated PLHIV

www.ghspjournal.org

Box. Description of Planned Activities During Each Counseling Visit

Visit 1:

N
N

Personalized assessment of risk behaviors

N

Overview of HIV transmission and prevention strategies using a flipchart

Identification of specific areas of need, for example, condom-related misconceptions, nondisclosure of HIV status to spouse/main partner

Visit 2:

N
N
N
N

Review of key prevention needs

N

Counseling on need for registration at HIV treatment and care center

Motivation on risk reduction and goal setting
Assistance with counseling for untested partners and facilitation of HIV testing for partners
Facilitation of referrals to services for prevention of mother-to-child transmission of HIV (PMTCT),
family planning, or treatment of sexually transmitted infections (STIs) per need

Visit 3:

N
N

Review of progress toward goals set during previous visit

N

Discussion of and referrals for testing of children and other family members

Follow-up on referrals made to STI or family planning clinics, HIV treatment and care centers, or
PMTCT services

Visit 4:

N
N

Review of key prevention message
Follow up on disclosure, risk-reduction goals, and partner testing

Participants could request additional visits.

PLHIV in the control group but without a
specified visit schedule or defined counseling
content. Data on the number of CHW encounters
with controls were not collected.
CHWs were paid a stipend of KSh2,000
(US$27) per month based on the national
guidelines, plus reimbursement for transportation costs. Study participants received KSh150
(US$2) as compensation for time spent completing the baseline and endline assessments.

Data Collection
Participants in both groups completed baseline
(pre-intervention) and endline (post-intervention) assessments. Data were collected on sociodemographic characteristics, sexual behavior,
perceived stigma, and receipt of ART through
face-to-face interviews, conducted in Swahili by
Global Health: Science and Practice 2013 | Volume 1 | Number 1

trained interviewers. Data were entered using
Computer-Assisted Personal Interview (CAPI).
However, information on more sensitive behaviors
was collected by the participants themselves using
Audio Computer-Assisted Self-Interview (ACASI);
the interviewer left the room after guiding the
participant on the technique.19 All response
options were color-coded and linked to audio
directions in Swahili. The interviewer was available outside the door to help the participant in case
s/he was unable to understand a particular question or had difficulty with the computer program.

Measures
Sexual behavior data were collected on the
number and type of sexual partners, condom
use, and disclosure of own status to partners.
Participants could report on up to 6 of their most
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recent sexual partners in the 3 months prior
to the survey. A regular partner was defined as
a cohabiting partner, and a casual partner as a
partner with whom the participant was not living
and had sex with once or rarely. A commercial
partner was one in which money or gifts were
exchanged for sex. Concurrent sexual relationships were based on overlapping dates for 2 or
more partners.
While unprotected sex is considered an important outcome, with unprotected sex between 2
PLHIV carrying risks, the study focused on the
outcome of unsafe sex. This outcome, a subset of
unprotected sex, was defined as sex without
condoms with a partner who is of negative or
unknown/untested HIV status.
Condom use fatigue was assessed using a
4-item Likert scale from strongly agree to
strongly disagree with the statement: ‘‘I am tired
of always having to make sure that I use a
condom every time I have sex.’’1 Condom use
self-efficacy was assessed using a 15-item scale
(Cronbach’s alpha50.79) derived from the
Condom Use Self-Efficacy Scale (CUSES)
(Cronbach’s alpha50.91).20-21 The scale included
items assessing the mechanics of using a
condom, partner’s disapproval of using a condom, assertiveness, and condom use under the
influence of intoxicants. Participants responded
on a 5-item Likert scale from strongly agree to
strongly disagree. Total scores (possible range
15–75) were categorized as low (15–34), moderate (35–54), or high self-efficacy (55–75).
Perceived internalized stigma was assessed
using a 16-item scale (Cronbach’s alpha of
adapted scale50.81) derived from Berger’s
HIV stigma scale (Cronbach’s alpha50.96).22
The scale covered 4 domains with 4 items for
each domain: personalized stigma, disclosure
concerns, negative self-image, and public attitudes. Participants responded on a 4-item Likert
scale from strongly agree to strongly disagree.
Total scores (possible range 16–64) were categorized as low (16–40), moderate (41–52), or
high stigma (53–64).
A 5-item test with a composite total correct
response score was used to assess HIV knowledge. The test included items on transmission of
HIV through mosquito bites, transmission
through sharing of utensils, transmission from
mother to child, reduction of HIV-transmission
risk with ART, and re-infection with new viral
strains. Concerns about HIV transmission were
assessed using 2 statements (4-item Likert scale
Global Health: Science and Practice 2013 | Volume 1 | Number 1
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from strongly agree to strongly disagree) derived
from an HIV treatment optimism-skepticism
scale: ‘‘New treatments take the worry out of
sex’’ and ‘‘I am less concerned about infecting
sexual partners.’’23

Data Analysis
Data were analyzed at 2 levels: within each group
to document changes in key sexual and behavioral outcomes over time and between groups at
endline. Stata 12.1 was used for data analysis.
Preliminary analyses showed that there were
imbalances between some socio-demographic
variables in the intervention and control groups,
which potentially introduce selection bias. We
addressed this by using propensity score matching (PSM), a technique useful for estimating
causal effects in non-randomized studies and for
removing selection bias.24,25
To select variables to include in matching, we
used a multivariate logistic regression model to
calculate the participants’ propensity to being
included in the intervention group. The intervention or control group was thus the model outcome,
and explanatory variables were the variables that
were unbalanced or likely to be associated with
exposure to the study intervention.
Post-logistic regression we extracted the
propensity scores, which showed different distributions in the 2 arms. Finally, Kernel caliper
matching was conducted on 5 variables: age,
gender, education, religion, and employment.26
Matching was effective in balancing all variables.
Statistical analyses were conducted on the
original and matched data.
Pearson’s chi-square test, t-test, and MannWhitney tests were used to compare groups on
categorical and continuous variables at baseline.
Wilcoxon signed rank tests, McNemar test, and
tests of marginal homogeneity (Stuart-Maxwell
and linear trend) for repeated measures on 2
related samples were used to document change
within groups over the 2 time periods. Pearson’s
chi-square test, chi-square test for trend, and
Wilcoxon rank sum test were used to compare
outcomes between the intervention and control
groups 6 months after the intervention. Finally,
we computed unadjusted odds ratios and 95%
confidence intervals (CI), comparing main study
outcomes between intervention and control
groups for the PSM samples. For all tests
performed, P values ,0.05 were considered
statistically significant.
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study participants in each group was 35 years, and
76.9% of participants in the intervention group
and 71.5% in the control group were women
(P50.12). Almost two-thirds of the participants
had only primary education while 28% had a
secondary or higher education (P50.87 comparing
education distribution in the 2 groups).
At baseline, differences were detected
between the intervention and control groups on
a number of characteristics. Notably, at baseline,
participants in the intervention group were more
likely than those in the control group to be single
or separated, to live alone, to be Catholic/
Protestant, and to report multiple HIV tests.
They were less likely to disclose their HIV status
to partners or others (Table 1).
In both groups, 38.5% of participants had
taken antiretroviral drugs previously (either for
ART or PMTCT) and a small number attended an
HIV clinic. Only a single participant reported

Participant Recruitment and Retention
At recruitment, 147 persons refused to participate in the study, 15.2% in the intervention
group and 15.4% in the control site; information
on the gender or socio-demographic profile of
these persons is not available. A total of 634
participants were enrolled (February–May 2010)
and 605 (95.4%) completed 6 months of followup, forming the analytic sample for the effectiveness analysis (Figure 1). In the intervention
group, 178 (56.5%) of the participants who
completed the study received the minimum 4
contact visits from CHWs, a further 136 participants (43.2%) were visited 5 times, and 1
participant was visited 6 times.
Table 1 provides details of the baseline characteristics of enrolled participants and participants
in the PSM sample (N5394). The average age of

FIGURE 1. Flow Diagram of Progress of HIV-Infected Study Participants Through the Study
Screened for eligibility (N=963)
• Intervenon (n=488)
• Control (n=475)

Excluded 34.2% (n=329)
• Ineligible 18.9% (n=182)
(Intervenon n=89, Control n=93)
• Refusal at community level 15.3% (n=147)
(Intervenon n=74, Control n=73)
Enrolled in study
65.8% (N=634)

Intervenon arm
(n=325)

Lost to follow-up
3.1% (n=10)

Completed 6 months follow-up
96.9% (n=315)

Global Health: Science and Practice 2013 | Volume 1 | Number 1

Control arm
(n=309)

Lost to follow-up
6.1% (n=19)

Completed 6 months follow-up
93.8% (n=290)
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TABLE 1. Baseline Characteristics of HIV-Infected Adults Enrolled in Intervention and Control Sites in Mombasa,
Kenya, and of a Propensity Score-Matched Selected Population
Enrolled Population
(N5634)

Propensity Score-Matched Population
(N5394)a

Intervention
(n5325)

Control
(n5309)

P Valueb

Intervention
(n5204)

Control
(n5190)

P Valueb

Female, n (%)

250 (76.9)

221 (71.5)

0.12

157 (77.0)

150 (79.0)

0.64

Age, mean years (SD)

35.2 (8.4)

35.6 (8.2)

0.51c

35.1 (8.6)

34.6 (7.9)

0.54c

30 (9.2)

30 (9.7)

18 (8.8)

21 (11.1)

206 (63.4)

190 (61.5)

130 (63.7)

109 (57.4)

89 (27.4)

89 (28.8)

56 (27.4)

60 (31.6)

Married or cohabiting

98 (30.2)

165 (53.4)

67 (32.8)

96 (50.5)

Single

78 (24.0)

47 (15.2)

48 (23.5)

29 (15.4)

Separated or divorced

80 (24.6)

51 (16.5)

45 (22.1)

35 (18.4)

Widowed

69 (21.2)

46 (14.9)

44 (21.6)

30 (15.8)

Stays alone

163 (50.2)

67 (21.7)

94 (46.1)

47 (24.7)

Nuclear family

103 (31.7)

193 (62.5)

70 (34.3)

116 (61.1)

59 (18.2)

49 (15.9)

40 (19.6)

27 (14.2)

Catholic

120 (36.9)

35 (11.3)

49 (24.0)

31 (16.3)

Protestant

135 (41.5)

109 (35.3)

93 (45.9)

101 (53.2)

66 (20.3)

164 (53.1)

62 (30.4)

57 (30.0)

4 (1.2)

1 (0.3)

Salaried job or self-employed

56 (17.2)

33 (10.7)

29 (14.2)

27 (14.2)

Daily wage worker

88 (27.1)

71 (23.0)

61 (29.9)

50 (26.3)

Vendor or hawker

55 (17.0)

76 (24.5)

50 (24.5)

51 (26.8)

Green grocer

15 (4.6)

10 (3.2)

7 (3.4)

7 (3.7)

Unemployed

49 (15.1)

49 (15.9)

36 (17.7)

34 (17.9)

Other

34 (10.5)

36 (11.7)

21 (10.3)

21 (11.1)

Variable
Socio-Demographic Characteristics

Education, n (%)
No schooling
Primary education
Secondary or higher education

0.87

0.42

Marital status, n (%)

,0.001*

0.004*

Living arrangements, n (%)

Extended family/friends

,0.001*

,0.001*

Religion, n (%)

Muslim
No religion

,0.001*

…

1 (0.5)

0.17

Employment, n (%)

Global Health: Science and Practice 2013 | Volume 1 | Number 1
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0.98

58

Effectiveness of HIV-prevention intervention provided by CHWs to untreated PLHIV

www.ghspjournal.org

TABLE 1 (continued).
Enrolled Population
(N5634)
Intervention
(n5325)

Control
(n5309)

1

165 (50.8)

2-4

Variable

Propensity Score-Matched Population
(N5394)a
Intervention
(n5204)

Control
(n5190)

207 (67.2)

104 (51.0)

126 (66.3)

139 (42.8)

92 (29.9)

87 (42.7)

58 (30.5)

21 (6.5)

9 (2.9)

13 (6.4)

6 (3.2)

P Valueb

P Valueb

HIV-Related Characteristics
Number HIV tests done, n (%)e

5 or more

,0.001*

0.007*

Months since HIV-positive diagnosis, n (%)e
0-11

83 (25.9)

102 (34.6)

51 (25.4)

61 (34.1)

12-23

74 (23.1)

69 (23.4)

46 (22.9)

42 (23.5)

163 (50.9)

124 (42.0)

0.040*

104 (51.7)

76 (42.5)

0.12

125 (38.5)

119 (38.5)

0.59

75 (36.8)

66 (34.7)

0.68

4 (1.2)

14 (4.5)

3 (1.5)

9 (4.7)

0.06

24 or more
Ever taken antiretroviral drugs
(including for PMTCT), n (%)
Currently attends HIV clinic

0.012*

Disclosed HIV status to main partner, n (%)e
Yes

160 (51.3)

203 (70.7)

102 (52.0)

121 (68.8)

No, but plans to disclose

67 (21.5)

41 (14.3)

39 (19.9)

29 (16.5)

No, does not intend to disclose

46 (14.7)

27 (9.4)

30 (15.3)

17 (9.7)

No, cannot say/maybe will disclose

39 (12.5)

16 (5.6)

,0.001*

25 (12.8)

9 (5.1)

0.004*

245 (75.4)

272 (88.0)

,0.001*

157 (77.0)

164 (86.3)

0.02*

18
(15–19, 7–42)

18
(15–19, 7–35)

0.91d

18
(9–25, 7–42)

17
(11–26, 7–35)

0.30d

Number lifetime partners, median
n (IQR, range)

5
(3–9, 1–53)

4
(3–9, 1–57)

0.49d

5
(1–20, 1–30)

4
(1–35, 1–57)

0.28d

Ever had same sex partners, n (%)

17 (5.2)

15 (4.9)

0.86

8 (3.9)

10 (5.3)

0.52

Has regular sexual partner(s), n (%)

312 (96.0)

287 (92.7)

0.093

79 (42.9)

44 (24.9)

,0.001*

Disclosed HIV status to anyone
besides health workers, n (%)
Sexual Behavior Characteristics
Age at first sex, median n
(IQR, range)

Global Health: Science and Practice 2013 | Volume 1 | Number 1
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TABLE 1 (continued).
Enrolled Population
(N5634)

Propensity Score-Matched Population
(N5394)a

Intervention
(n5325)

Control
(n5309)

P Valueb

Intervention
(n5204)

Control
(n5190)

P Valueb

Has children, n (%)

281 (86.5)

265 (85.8)

0.80

176 (86.3)

162 (85.3)

0.77

Currently using family planning, n (%)

187 (57.5)

163 (52.8)

0.46

112 (58.0)

96 (53.9)

0.33

Variable

Abbreviations: SD, standard deviation; PMTCT, prevention of mother-to-child transmission; IQR, interquartile range.
* P values , 0.05 were considered statistically significant.
a
The following variables were used in propensity score matching: age, gender, education, religion, and employment.
b
Pearson’s chi-square test unless otherwise indicated.
c
t -test.
d
Mann-Whitney test.
e
For the enrolled population, sample size of control group for number of HIV tests done is 308; of intervention and control group for months since HIV-positive
diagnosis is 320 and 295, respectively; of intervention and control group for disclosed HIV status to main partner is 312 and 287, respectively.

injection drug use in the past 6 months (data not
shown). The majority of participants in both
groups had regular sexual partners (.92%;
P50.093) and biological children (86.5% in
intervention and 85.8% in controls; P50.80),
and more than half of participants in each group
were currently using family planning.

Behavior Change in Study Sample
Compared with baseline, at endline, the
proportion of participants in the intervention

group reporting a number of risky sexual
behaviors declined considerably, including
having multiple partners (2 or more partners
in the past 3 months), concurrent relationships
in the past 3 months (41.7% at baseline versus
18.2% at endline; P50.015; data not shown),
unprotected sex with various partners at
last sex, unprotected sex acts in the last
month, and unsafe sex in the last month (with
partners of negative or unknown HIV status)
(Table 2).

The percentage of
study participants
who reported
risky sex behaviors declined over
time.

TABLE 2. Sexual and Behavioral Outcomes Among HIV-Infected Men and Women Before and 6 Months After a
Behavioral Intervention in Mombasa, Kenya (N5605)
Intervention (n5315)
Before
n/N (%)

Variable

After
n/N (%)

Control (n5290)
P Valuea

Before
n/N (%)

After
n/N (%)

9/283 (3.2)

54/286 (18.9)

P Valuea

Number of partners in past 3 months
0 partners

11/297 (3.7)

58/313 (18.5)

1 partner

158/297 (53.2)

202/313 (64.5)

>2 partners

201/283 (71.0) 174/286 (60.8)
73/283 (25.8)

58/286 (20.3)

0.06b

,0.001*

97/144 (67.4)

85/141 (60.3)

0.19

4/92 (4.4)

,0.001*

56/125 (44.8)

54/105 (51.4)

1.00

89/142 (62.7)

11/101 (10.9)

,0.001*

15/31 (48.4)

20/33 (60.6)

1.00

36/53 (67.9)

2/33 (6.1)

0.025*

25/43 (58.1)

13/28 (46.4)

0.025*

128/297 (43.1)

53/313 (16.9)

,0.001*

68/93 (73.1)

9/79 (11.4)

Regular partner

71/115 (61.7)

Casual partner

b

Unprotected sex at last sexc,d
Spouse

Commercial partner
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TABLE 2 (continued).
Intervention (n5315)
Variable

Before
n/N (%)

After
n/N (%)

Control (n5290)
P Valuea

Before
n/N (%)

After
n/N (%)

P Valuea

Unprotected sex in past monthd,e
0 acts
1-5 acts
>6 or more acts

115/307 (37.5)

225/258 (87.2)

87/307 (28.4)

28/258 (10.9)

115/282 (40.8) 126/238 (52.9)
b

102/282 (36.1)

69/238 (29.0)

65/282 (23.1)

43/238 (18.1)

0.002*

b

0.003*

b

105/307 (34.2)

5/258 (1.9)

0 HIV-negative or
unknown status partner

137/307 (44.6)

240/258 (93.0)

1 HIV-negative or
unknown status partner

23/307 (7.5)

4/258 (1.6)

26/282 (9.2)

10/238 (4.2)

2-5 HIV-negative or
unknown status partners

59/307 (19.2)

10/258 (3.9)

43/282 (15.3)

33/238 (13.9)

>6 HIV-negative or
unknown status partners

88/307 (28.7)

4/258 (1.6)

41/282 (14.5)

27/238 (11.3)

23/315 (7.3)

2/315 (0.6)

Moderate self-efficacy
(score 35-54)

169/315 (53.7)

31/315 (9.8)

High self-efficacy
(score 55-75)

123/315 (39.1)

282/315 (89.5)

,0.001*

153/290 (52.8) 143/290 (49.3)

0.86

65/93 (70.0)

74/79 (93.7)

,0.001*

120/144 (83.3) 125/141 (88.7)

0.083

Regular partner(s)

16/115 (13.9)

8/92 (8.7)

0.65

Casual partner(s)

19/142 (13.4)

10/101 (9.9)

1.00
0.16

,0.001*

Unsafe sex in past monthd,e
172/282 (61.0) 168/238 (70.6)

,0.001*

b

Condom use self-efficacy
Low self-efficacy
(score 15-34)

8/290 (2.8)

0/290 (0)

129/290 (44.5) 147/290 (50.7)

HIV status disclosed to partnerc,d
Spouse

Commercial partner(s)
Currently receiving
antiretroviral treatment

8/53 (15.1)

7/33 (21.2)

11/125 (8.8)

16/105 (15.2)

0.41

7/31 (22.6)

12/33 (36.4)

1.00

6/43 (14.0)

7/28 (25.0)

0.56

1/315 (0.3)

111/315 (35.2)

78/314 (24.8)

133/314 (42.4)

152/290 (52.4) 172/290 (59.3)

Moderate (score 41-52) 232/314 (73.9)

181/314 (57.6)

134/290 (46.2) 113/290 (39.0)

,0.001*

1/290 (0.3)

36/290 (12.4)

,0.001*

Internalized stigma
Low (score 16-40)
High (score 53-64)

4/314 (1.3)

0/31 (0)

,0.001*

4/290 (1.4)

5/290 (1.7)

0.09

* P values , 0.05 were considered statistically significant.
a
McNemar test unless otherwise indicated.
b
Marginal homogeneity (Stuart-Maxwell) test.
c
Multiple-response question.
d
Respondents were asked to report on all sexual partners in the past 3 months with a maximum of 6 partners.
e
Only among sexually active participants.
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In the control group, fewer and smaller
changes were observed. However, significant
reductions were observed in the percentage of
control participants reporting unprotected sex at
last sex with sex workers (P50.025), unprotected
sex in the past month (P50.002), and unsafe sex
in the last month (P50.003) (Table 2).
Condom use fatigue was reported by around
half the participants and did not significantly
change over time in either group (data not
shown). In the intervention group, an increasing
proportion of participants reported high condom
use self-efficacy (39.1% at baseline versus 89.5%
at endline; P,0.001) while there was no increase
in the control group.
The percentage of intervention participants
reporting disclosure of HIV status to their
spouse increased significantly from baseline to
endline (70.0% versus 93.7%; P,0.001) and to
some extent in the control group (83.3% versus
88.7%; P50.083). In both groups, however, no
statistically significant change was detected in
disclosure to other types of partners. Internalized
stigma scores declined in the intervention arm
(P,0.001).
ART uptake, negligible in both populations
at baseline, increased in the intervention (0.3%
versus 35.2%; P,0.001) and control (0.3% versus
12.4%; P,0.001) groups over time, but it was
almost three-fold higher in the intervention
group than in the control group at endline
(P,0.001). Overall, ART-experienced participants were more likely to initiate ART compared
with ART-naı̈ve participants (56.5% versus
32.6%; P,0.001).

Behavior Change in Propensity Score
Matched-Sample
Table 3 presents sexual and behavioral outcomes
at endline among men and women with HIV in
the intervention and control groups in the PSM
sample. At endline, fewer participants in the
intervention arm than in the control arm
reported unprotected sex at last sex: with
a spouse (9.1% versus 56.1%; Odds Ratio
[OR]50.08, 95% confidence interval [CI]50.030.24), with a regular partner (5.1% versus 48.5%;
OR50.06, 95% CI50.01-0.24), with a casual
partner (15.4% versus 60.0%; OR50.12, 95%
CI50.04-0.39), and with a sex worker (8.7%
versus 47.4%; OR50.11, 95% CI50.02-0.72).
Overall, participants in the intervention group
reported fewer numbers of unprotected sex
acts in the past month than participants in the
Global Health: Science and Practice 2013 | Volume 1 | Number 1

control group (P,0.001). Also, they were less
likely to report unsafe sex with any partner with
negative or unknown HIV status in the last
month (P,0.001); 92.4% of the intervention
participants reported no unsafe sex acts compared with 70.8% of control-group participants.
Knowledge of HIV transmission was
higher in the intervention group than in the
control group (median score55 [IQR: 2-5] versus
4 [IQR: 1-5], respectively; P,0.001; data not
shown). At endline, more participants in the
intervention arm than in the control arm
exhibited high condom use self-efficacy scores
(88.7% versus 52.6%), and had higher median
scores on the knowledge of HIV transmission
index (score55 [IQR52-5] versus 4 [IQR51-5];
P,0.001; data not shown).
More participants in the intervention arm
than the control arm were receiving ART by
endline (34.3% versus 12.7%; OR51.62, 95%
CI51.07-2.46). Interestingly, a higher proportion
of participants in the control group had low
internalized stigma scores at endline compared
with those in the intervention group (44.3%
versus 56.3%). At endline, more participants in
the intervention group than in the control group
reported less concern about HIV transmission
due to ART availability (84.2% versus 42.1%;
OR57.3, 95% CI54.3-12.5; data not shown).
Finally, analysis of outcomes separately by
gender showed that all changes were in the
same direction and of similar magnitude in
women and men, with no differences detected
in effect by gender.

www.ghspjournal.org

ART uptake
increased significantly over time in
both intervention
and control
groups but more
so in the intervention group.

DISCUSSION
CHWs delivered a personalized HIV risk-reduction intervention that was successful in reducing
reported risky behaviors (for example, improved
condom use resulting in fewer unprotected sex
acts and less unsafe sex) in a cohort of PLHIV
who knew their HIV status but were not
accessing HIV treatment or care services. The
intervention also increased HIV knowledge and
ART uptake.
Several studies have evaluated HIV-prevention
interventions, but nearly all have been conducted
among PLHIV recruited from HIV care or prevention services.2,4-9 To our knowledge, this is the first
study to be conducted among PLHIV who are not
accessing HIV services, with more than 40% of the
participants testing positive with HIV more than
24 months previously.

PLHIV in the intervention group
were less likely
those in the control group to
report risky sex
behaviors.
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TABLE 3. Propensity Score-Matcheda Sexual and Behavioral Outcomes Among HIV-Infected
Men and Women After a 6-Month Behavioral Intervention (N5394)
End of study
Variable

P Valueb

Intervention n/N (%)

Control n/N (%)

0 partners

36/204 (17.7)

34/190 (17.9)

1 partner

135/204 (66.2)

119/190 (62.6)

33/204 (16.2)

37/190 (19.5)

0.61c

Spouse

5/55 (9.1)

55/98 (56.1)

,0.001*

Regular partner

3/59 (5.1)

33/68 (48.5)

,0.001*

Casual partner

10/65 (15.4)

15/25 (60.0)

,0.001*

2/23 (8.7)

9/19 (47.4)

0.005*

Number of partners in past 3 months

>2 partners
Unprotected sex at last sexd,e

Commercial partner
Unprotected sex in past monthe,f
0 acts

150/171 (87.7)

87/161 (54.0)

1 acts

5/171 (2.9)

11/161 (6.8)

11/171 (6.4)

36/161 (22.4)

5/171 (2.9)

27/161 (16.8)

0 HIV-negative or unknown-status partner

158/171 (92.4)

114/161 (70.8)

1 HIV-negative or unknown-status partner

3/171 (1.8)

6/161 (3.7)

2-5 HIV-negative or unknown-status partners

5/171 (3.5)

22/161 (13.7)

>6 HIV-negative or unknown-status partners

4/171 (2.3)

19/161 (11.8)

2-5 acts
6 or more acts

,0.001*

c

Unsafe sex in past monthe,f

,0.001*

c

Condom use self-efficacy
Low self-efficacy (score 15-34)
Moderate self-efficacy (score 35-54)

2/204 (1.0)

0/190 (0)

21/204 (10.3)

90/190 (47.4)

181/204 (88.7)

100/190 (52.6)

52/55 (94.5)

89/98 (90.8)

0.41

Regular partner(s)

5/59 (8.5)

10/68 (14.7)

0.28

Casual partner(s)

6/65 (9.2)

9/25 (36.0)

0.002*

Commercial partner(s)

5/23 (21.7)

6/19 (31.6)

0.47

High self-efficacy (score 55-75)

,0.001*

c

HIV status disclosed to partnerd,e
Spouse
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TABLE 3 (continued).
End of study
Variable

Intervention n/N (%)

Control n/N (%)

P Valueb

70/204 (34.3)

24/189 (12.7)

,0.001*

90/203 (44.3)

107/190 (56.3)

113/203 (55.7)

81/190 (42.6)

0/203 (0.0)

2/190 (1.1)

Currently receiving antiretroviral treatment
Internalized stigma
Low (score 16-40)
Moderate (score 41-52)
High (score 53-64)

0.034*

c

* P values , 0.05 were considered statistically significant.
a
The following variables were used in propensity score matching: age, gender, education, religion, and employment.
b
Pearson’s chi-square test unless otherwise indicated.
c
Chi-square test for trend.
d
Multiple-response question.
e
Respondents were asked to report on all their sexual partners in the past 3 months with a maximum of 6 partners.
f
Only among sexually active participants.

Clients with HIV were recruited from the
community, and the intervention was delivered
by CHWs. While this is in variance with
recommendations for successful HIV-prevention
interventions made in a meta-analysis by Crepaz
et al.,4 our findings provide evidence that nonformal health care providers can deliver interventions in non-clinical settings. The studies in
the Crepaz review were conducted in the United
States and suggested that provision of interventions by health care providers in service settings
were effective in those settings.4 Shortage of
human resources is a recognized limitation of
health programs in several African countries and
task shifting to other cadres is often considered.
In this study, CHWs successfully delivered the
intervention without any evidence of breaching
confidentiality. Peltzer et al. (2010)27 also
reported successful outcomes (increases in HIV
knowledge, behavioral intentions, and riskreduction efficacy, and declines in number of
sex partners and unprotected sex) among persons with HIV receiving a risk-reduction intervention delivered by lay counselors at HTC
services in South Africa.
Of note, nearly three-quarters of the participants were women, who constitute 60% of all
adults with HIV in Kenya and in sub-Saharan
Africa more broadly.28 There are several possible
reasons for higher recruitment of women than
men. For example, women might have been
easier to reach in their homes by CHWs and more
Global Health: Science and Practice 2013 | Volume 1 | Number 1

responsive to being included in a study, while
men might have been more mobile. Also, more
women might know their HIV status than men,
often through contacts with the health system,
such as antenatal clinics. Specific efforts are
needed to recruit men, as they often make up
a much smaller proportion within studies, HIV
services, and health programs more generally.
Employing more male CHWs might be useful.
Interestingly, in addition to the decline in
numbers of reported partners in the intervention
group, we observed a marginally significant
reduction in the reported number of partners in
the control group. It is possible that limited
behavior change occurred among participants in
the control group through the more limited
contact with CHWs and participation in the
research study. Nevertheless, future interventions should specifically focus on partner number
as a critical concern.
Although reported disclosure of HIV status
to spouses increased, disclosure to regular,
casual, or commercial sex partners did not
change in either group. Several other papers also
report high disclosure rates within the marital
union29-31 and lower rates of disclosure among
previous or current casual partners.31 Within
these transient or infrequent relationships,
people might perceive a lower overall level of
responsibility. While future research should
explore disclosure and its context with casual
and paid partners, the intervention could be
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further strengthened by specifically emphasizing
disclosure to non-regular partners.
We noted a shift to lower internalized
stigma scores in the intervention group compared with the control group in the study
sample. However, the proportion of participants
with low stigma scores was higher in the
control group compared with the intervention
group in the PSM sample at endline. The
intervention focused on HIV risk reduction and
emphasized disclosure to partners and family
members. It is possible that frequent contact
with CHWs and their guidance to disclose might
have contributed to increased self-perceived
stigma among intervention participants, at least
in the short-term. In the long-term, however,
disclosure of HIV status to spouses or main
partners is associated with greater acceptance
and support from partners, which includes
anxiety relief, increased sexual communication,
increased care-seeking behavior including ART
uptake, and motivation to plan for the future
among PLHIV.31,33-34
About half the participants in both groups
expressed condom use fatigue, or being tired of
always using condoms. The proportion of participants expressing condom use fatigue did not
change over time and did not translate into an
increase in unprotected sex; nevertheless, the
impact of this over the long-term warrants
concern.

Study Limitations
The results should be interpreted in light of study
limitations. Critically, the study relies on selfreported sexual risk and condom use behaviors,
which might be subject to social desirability and
recall bias. We used a 3-month recall period and
limited the number of partners that each
participant could report on to a maximum of 6,
with the aim of obtaining more reliable recall
and limiting the influence of outliers in the
sample. Reviews of validity and reliability of HIV
research show that sexual behavior data are
fairly consistent and self-reported data on sexual
acts are reasonably congruent, especially for
Community-based short recall periods.35-36
delivery of posiFurthermore, a sizeable proportion of particitive prevention
pants reported condom use fatigue, which could
interventions
be considered to support the veracity of selfshows promise for reported condom use behaviors. However, partilarge-scale repli- cipants in the intervention group did receive
cation in resource- additional counseling and follow-up, which might
limited settings.
heighten desirability bias and improve recall
Global Health: Science and Practice 2013 | Volume 1 | Number 1
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in this group. The study would have benefited
from clinical indicators or biological markers for
unprotected sex to validate the results.
Further research is needed to demonstrate
behavior change, not just reported behaviors.
Our study did have one behavioral indicator
(ART uptake) that showed a positive result in
favor of the intervention.
We recruited PLHIV through non-probability
targeted sampling using CHWs to reach potential
participants, which might have introduced
selection bias. Although our sample was not
randomly recruited, we were able to reach PLHIV
in the community, who are otherwise not
accessible. Individual-level randomization would
have controlled for the differences between the 2
groups at baseline. However, to remove the
chance of intervention diffusion into the control
group, we randomly assigned study sites to the 2
arms. Using PSM analysis, we were able to
account for some differences, and findings were
supported by results obtained from analysis over
time in the entire study sample.
Some limitations of PSM warrant mention.
The potential remains for unmeasured confounding and the smaller sample size resulting from
this method limits the ability to detect smaller
differences between the study groups.
The study tools had some limitations as well.
The HIV knowledge index did not include an
item on the awareness of HIV risk through
sharing of needles/syringes among IDUs or
unprotected sex with IDU partners. Recent
studies have documented the presence of a
sizeable IDU population in Mombasa, and future
studies should include this information.37-38
Data were also not collected on some
important variables such as CD4 cell count and
access to health services. These variables could
thus not be included in the PSM analysis. It is
possible that the differences in ART uptake noted
between the intervention and control site might
have been due, in some part, to differences in
baseline levels of CD4 cell count between
participants in these areas.
Finally, given the specificities of the study
location and the non-randomized study design,
the findings of this research might not be
generalizable to other settings. Moreover, our
study sample was recruited from among PLHIV
who know their HIV status, and our findings
might not be applicable to PLHIV who have not
been tested.
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CONCLUSION
In conclusion, the community-based positive
prevention intervention effectively reduced
reported risky sexual behavior and increased
ART uptake among PLHIV who knew their HIV
status. As the intervention was delivered by nonformal health care providers from the community using a national CHW training package, we
consider it suitable for large-scale replication in
similar resource-limited settings. Strategies to
reach more PLHIV in the community, especially
men who are not accessing services, need further
research, as do the effects of interventions that
target structural and other forms of vulnerability,
in addition to the behavioral interventions
applied here. Finally, the long-term effects and
sustainability of this intervention warrant
further assessment, perhaps within a longitudinal study.
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